Gefarnate

Gefarnate is a drug used for the treatment of gastric ulcers.^[1]

Gefarnate

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	A02BX07 (WHO)
Identifiers
IUPAC name (2E)-3,7-dimethylocta-2,6-dien-1-yl (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
CAS Number	51-77-4 Y
PubChem CID	5282182
ChemSpider	4445377 N
UNII	1ISE2Y6ULA
KEGG	D01529 Y
ChEMBL	ChEMBL2105085 N
CompTox Dashboard (EPA)	DTXSID0048636
ECHA InfoCard	100.000.111
Chemical and physical data
Formula	C27H44O2
Molar mass	400.647 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(C)/CCC=C(C)C
InChI InChI=1S/C27H44O2/c1-22(2)12-8-14-24(5)16-10-17-25(6)18-11-19-27(28)29-21-20-26(7)15-9-13-23(3)4/h12-13,16,18,20H,8-11,14-15,17,19,21H2,1-7H3/b24-16+,25-18+,26-20+ N Key:ZPACYDRSPFRDHO-ROBAGEODSA-N N
NY (what is this?)  (verify)

It also has been proposed for use in the treatment of dry eye syndrome.^[2][3]